One common pitfall is trying five new things at once and then not knowing what helped or what caused side effects
Hyperglycemia-induced cellular damage causes oxidative stress (i.e
found that the presence of MASLD and clinically significant fibrosis was associated with about a 4.5-fold higher risk of worse glycemic control at follow-up (defined as an HbA1c increase 0.5 % from baseline), even after adjustment for age, BMI, baseline HbA1c (or HOMA-estimated insulin resistance), and the use of glucose-lowering medications, such as pioglitazone, glucagon-like peptide-1 (GLP-1) receptor agonists, or sodium-glucose cotransporter 2 (SGLT2) inhibitors (Mantovani et al., 2022[49])
[12] In July 2022, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending granting a marketing authorization for the medicinal product Mounjaro, intended for the treatment of type 2 diabetes
The patients were mostly women (56.7%
This GLP-R1 agonist seems to increase oncogenesis in multiple tissues, including the thyroid, bladder, pancreatic, and colorectal [97, 110, 121]